Drug intelligence / Profile preview

LF+

Development stage: Unknown
Lead developer: TurtleTree
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

LF+ is a precision fermentation-derived, animal-free form of lactoferrin developed by TurtleTree. Lactoferrin is a multifunctional glycoprotein naturally found in milk and other secretory fluids, known for its antimicrobial, antiviral, anti-inflammatory, and immune-modulating properties. TurtleTree's LF+ is notable for being the first vegan-certified lactoferrin product globally, produced without animal sources to meet the needs of conscious consumers seeking sustainable nutrition alternatives[8].

Brand names: LF+
Other names: TurtleTree LF+ lactoferrin

Targets

Fe3+ (Ferric iron)

Beyond the preview

Go deeper on LF+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LF+.

Explore the full profile